➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Merck
Express Scripts
Boehringer Ingelheim
McKesson

Last Updated: September 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OLOPATADINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Olopatadine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00331500 ↗ Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis Completed Alcon Research Phase 3 2006-08-01 The purpose of this study is to demonstrate that Olopatadine 0.2% is superior to vehicle in the treatment of the signs and symptoms associated with allergic conjunctivitis or rhinoconjunctivitis.
NCT00389025 ↗ Mast-Cell Stabilizing Effects of Olopatadine Completed Alcon Research Phase 4 2006-10-01 To assess the effects of olopatadine of the release of mast cell histamine
NCT00489398 ↗ Comparison of CL Wear Between Two Allergy Drops Withdrawn Merck Sharp & Dohme Corp. Phase 4 2007-07-01 Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
NCT00489398 ↗ Comparison of CL Wear Between Two Allergy Drops Withdrawn Hom, Milton M., OD, FAAO Phase 4 2007-07-01 Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Olopatadine Hydrochloride

Condition Name

Condition Name for Olopatadine Hydrochloride
Intervention Trials
Allergic Conjunctivitis 19
Seasonal Allergic Rhinitis 5
Conjunctivitis, Allergic 5
Allergic Rhinitis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Olopatadine Hydrochloride
Intervention Trials
Conjunctivitis, Allergic 28
Conjunctivitis 27
Rhinitis 14
Rhinitis, Allergic 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Olopatadine Hydrochloride

Trials by Country

Trials by Country for Olopatadine Hydrochloride
Location Trials
United States 57
Canada 4
Japan 4
India 2
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Olopatadine Hydrochloride
Location Trials
Texas 9
Massachusetts 4
Tennessee 3
Wisconsin 3
Illinois 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Olopatadine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Olopatadine Hydrochloride
Clinical Trial Phase Trials
Phase 4 20
Phase 3 13
Phase 2 5
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Olopatadine Hydrochloride
Clinical Trial Phase Trials
Completed 33
Recruiting 3
Withdrawn 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Olopatadine Hydrochloride

Sponsor Name

Sponsor Name for Olopatadine Hydrochloride
Sponsor Trials
Alcon Research 20
Allergan 3
Merck Sharp & Dohme Corp. 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Olopatadine Hydrochloride
Sponsor Trials
Industry 36
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Johnson and Johnson
Medtronic
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.